Deep Track Capital, LP
GREENWICH, CT · CIK 1856083 · 13F filing filed 2023-09-06
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyGreenwich, CT
$2.1bn
reported value
-9.0% vs Q1 2023
53positions
51.6%in top 10
12 new
13 added
13 reduced
13 sold out
vs Q1 2023
Options: 1 call positions ($2.1m notional), 1 put positions ($17.1m notional) – listed below, not included above.
Holdings, Q2 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC JAZZ | $155.0m7.24% | Added +50.0k |
| INSMED INC INSM | $137.2m6.41% | Unchanged |
| IONIS PHARMACEUTICALS INC IONS | $116.3m5.43% | Unchanged |
| TRAVERE THERAPEUTICS INC TVTX | $113.2m5.29% | Added +1.2m |
| STRUCTURE THERAPEUTICS INC GPCR | $110.0m5.14% | Unchanged |
| IMMUNOVANT INC IMVT | $102.8m4.80% | Reduced -2.0m |
| INTRA-CELLULAR THERAPIES INC ITCI | $98.0m4.58% | Reduced -151.7k |
| ALKERMES PLC ALKS | $93.9m4.39% | Unchanged |
| SPRINGWORKS THERAPEUTICS INC SWTX | $93.0m4.34% | Added +446.4k |
| DYNAVAX TECHNOLOGIES CORP DVAX | $84.7m3.96% | Added +207.8k |
| GERON CORP GERN | $77.6m3.62% | Reduced -2.7m |
| PLIANT THERAPEUTICS INC PLRX | $73.4m3.43% | Added +627.9k |
| BICYCLE THERAPEUTICS PLC BCYC | $71.9m3.36% | Unchanged |
| VERONA PHARMA PLC VRNA | $67.4m3.15% | Unchanged |
| GUARDANT HEALTH INC GH | $53.7m2.51% | New |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $50.2m2.34% | Added +500.0k |
| AGENUS INC COM NEW | $48.0m2.24% | Unchanged |
| BEAM THERAPEUTICS INC BEAM | $42.1m1.96% | Added +67.3k |
| AUTOLUS THERAPEUTICS PLC AUTL | $35.7m1.67% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $34.1m1.59% | Added +130.9k |
| VIRIDIAN THERAPEUTICS INC VRDN | $30.4m1.42% | Added +49.2k |
| NURIX THERAPEUTICS INC NRIX | $29.9m1.40% | Unchanged |
| REPARE THERAPEUTICS INC RPTX | $28.9m1.35% | Unchanged |
| EDITAS MEDICINE INC EDIT | $28.4m1.33% | New |
| DYNE THERAPEUTICS INC DYN | $28.1m1.31% | Added +165.3k |
| ANI PHARMACEUTICALS INC ANIP | $27.7m1.29% | New |
| AXSOME THERAPEUTICS INC AXSM | $27.6m1.29% | New |
| POINT BIOPHARMA GLOBAL INC COM | $25.2m1.18% | Added +436.5k |
| EDGEWISE THERAPEUTICS INC EWTX | $21.3m1.00% | Reduced -318.3k |
| ZURA BIO LTD ZURA | $20.7m0.97% | New |
| PACIFIC BIOSCIENCES CALIF IN PACB | $19.3m0.90% | Reduced -2.1m |
| ACUMEN PHARMACEUTICALS INC ABOS | $18.8m0.88% | Reduced -35.6k |
| RAPT THERAPEUTICS INC COM | $18.8m0.88% | Added +433.3k |
| VIGIL NEUROSCIENCE INC VIGL | $16.7m0.78% | Reduced -251.7k |
| ASTRIA THERAPEUTICS INC CATB | $14.1m0.66% | Reduced -119.1k |
| NUVATION BIO INC NUVB | $13.9m0.65% | Unchanged |
| MORPHIC HLDG INC MORF | $12.4m0.58% | New |
| SILENCE THERAPEUTICS PLC SLN | $10.7m0.50% | Unchanged |
| ORCHARD THERAPEUTICS PLC ORTX | $10.6m0.50% | New |
| NEKTAR THERAPEUTICS COM | $10.3m0.48% | Added +16.2m |
| TERNS PHARMACEUTICALS INC COM | $9.6m0.45% | New |
| 89BIO INC ETNB | $9.5m0.45% | Reduced -1.3m |
| INOZYME PHARMA INC COM | $9.2m0.43% | Reduced -1.6m |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $8.5m0.40% | New |
| RELMADA THERAPEUTICS INC RLMD | $7.0m0.33% | Unchanged |
| GH RESEARCH PLC GHRS | $5.9m0.28% | Unchanged |
| COMPASS PATHWAYS PLC CMPS | $5.6m0.26% | New |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX | $5.5m0.26% | New |
| CENTURY THERAPEUTICS INC IPSC | $3.2m0.15% | Unchanged |
| HERON THERAPEUTICS INC HRTX | $2.4m0.11% | Reduced -1.1m |
| ALLAKOS INC ALLKG | $995.3k0.05% | Reduced -3.4m |
| IMMUNIC INC COM | $773.9k0.04% | Reduced -2.2m |
| MINK THERAPEUTICS INC COM | $682.2k0.03% | New |
Sold out since Q1 2023
| Security | Value then |
|---|---|
| IVERIC BIO INC OPHT | $158.1m6.5m shares |
| CHINOOK THERAPEUTICS INC ADRO | $69.5m3.0m shares |
| REATA PHARMACEUTICALS INC RETA | $66.3m729.0k shares |
| BIOGEN INC BIIB | $55.6m200.0k shares |
| DICE THERAPEUTICS INC | $45.8m1.6m shares |
| EXELIXIS INC EXEL | $37.5m1.9m shares |
| DECIPHERA PHARMACEUTICALS IN DCPH | $21.1m1.4m shares |
| UNIQURE NV QURE | $17.4m865.8k shares |
| ACLARIS THERAPEUTICS INC ACRS | $13.8m1.7m shares |
| JOUNCE THERAPEUTICS INC JNCE | $7.9m4.3m shares |
| ORCHARD THERAPEUTICS PLC | $6.3m1.2m shares |
| NKARTA INC NKTX | $4.8m1.4m shares |
| 2SEVENTY BIO INC TSVT | $3.6m350.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| PROTHENA CORP PLC PRTA · Put | $17.1m250.0k shares | New |
| FIBROGEN INC Call | $2.1m764.7k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 27.
| Company | Stake |
|---|---|
| LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10 | 11.7%≈ $108.8m |
| ALTIMMUNE INC ALT · 13G · filed 2026-04-30 | 10.0%≈ $59.0m |
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06 | 10.0%≈ $11.9m |
| VERASTEM INC VSTM · 13G · filed 2025-11-21 | 10.0%≈ $29.5m |
| COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17 | 10.0% |
| RAPT THERAPEUTICS INC 13G · filed 2024-12-23 | 9.9% |
| MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14 | 9.7%≈ $155.7m |
| OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15 | 9.5%≈ $204.7m |
| MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14 | 9.0%≈ $117.8m |
| IMMUNIC INC 13G · filed 2026-03-04 | 8.7% |
| ALECTOR INC ALEC · 13G · filed 2026-10-23 | 8.6%≈ $21.3m |
| TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15 | 8.5%≈ $226.6m |
| X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 | 8.3%≈ $37.6m |
| CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15 | 8.3%≈ $4.1m |
| HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08 | 8.2%≈ $132.3m |
| CORMEDIX INC CRMD · 13G · filed 2026-05-15 | 7.9%≈ $49.3m |
| NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14 | 7.5%≈ $187.7m |
| CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15 | 7.3%≈ $33.0m |
| ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17 | 7.0%≈ $49.4m |
| AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14 | 6.9%≈ $66.7m |
| MIND MEDICINE MINDMED INC 13G · filed 2025-11-14 | 6.9% |
| ENGENE HOLDINGS INC 13G · filed 2025-11-18 | 6.7% |
| BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15 | 6.2%≈ $120.6m |
| ALUMIS INC ALMS · 13G · filed 2026-04-07 | 6.0%≈ $207.2m |
| STRUCTURE THERAPEUTICS INC GPCR · 13G · filed 2026-02-13 | 6.0% |